Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-03-03 @ 4:14 AM
Study NCT ID:
NCT00866333
Status:
TERMINATED
Last Update Posted:
2019-10-22
First Post:
2009-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma
Sponsor:
Syndax Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04-13
Start Date Type:
None
Primary Completion Date:
2013-02-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-19
First Submit QC Date:
None
Study First Post Date:
2009-03-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-08-15
Results First Submit QC Date:
None
Results First Post Date:
2019-10-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-03
Last Update Post Date:
2019-10-22
Last Update Post Date Type:
ACTUAL